Pulmobiotics SL is a a spin off company from the Centre for Genomic Regulation (Barcelona - Spain) founded by experienced entrepreneurs and funded by invivo Ventures. Using a proprietary microbial engineering and synthetic biology toolbox our founders have created a platform based on attenuated lung bacteria that is able to expose antigens or deliver therapeutic agents in the lung in a controlled, local and continuous manner. Pulmobiotics SL will use this technology to discover and develop novel treatments and vaccines for respiratory diseases, which are among the most common causes of severe illness and death worldwide.
| Website | http://www.pulmobio.com |
| Employees | 4 (4 on RocketReach) |
| Founded | 2020 |
| Technologies |
JavaScript
,
HTML
,
Twitter
+7 more
(view full list)
|
| Industry | Biotechnology Research, Drug Discovery, Biotechnology |
| Keywords | Microbial Engineering, Microbial Therapeutics, Synthetic Biology, Respiratory Therapeutics, Microbial Technology, Genetic Engineering, Lung Health, Pulmonary Medicine, Drug Discovery, Innovative Therapies, Respiratory Research, Therapeutics Development, Drug Development, Biotechnology, Clinical Development, Pharmaceutical, Precision Medicine, Biopharma, Life Sciences |
| Competitors | Pfizer, Boehringer Ingelheim, Verily, Aptar Pharma, Novavax, CureVac, Pulmatrix Inc., MediBeacon Inc., Inhalon Biopharma, Proterris, Inc +37 more (view full list) |
Looking for a particular Pulmobiotics SL employee's phone or email?
4 people are employed at Pulmobiotics SL.
Pulmobiotics SL is based in Barcelona, Catalonia.